Search by Drug Name or NDC
NDC 00054-4858-25 Triazolam 0.125 mg/1 Details
Triazolam 0.125 mg/1
Triazolam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is TRIAZOLAM.
MedlinePlus Drug Summary
Triazolam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Triazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
Related Packages: 00054-4858-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Triazolam
Product Information
| NDC | 00054-4858 |
|---|---|
| Product ID | 0054-4858_5f2e46af-164a-4ca1-a126-823e4a4fe3e7 |
| Associated GPIs | 60201040000305 |
| GCN Sequence Number | 003693 |
| GCN Sequence Number Description | triazolam TABLET 0.125 MG ORAL |
| HIC3 | H21 |
| HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
| GCN | 14282 |
| HICL Sequence Number | 001594 |
| HICL Sequence Number Description | TRIAZOLAM |
| Brand/Generic | Generic |
| Proprietary Name | Triazolam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Triazolam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.125 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRIAZOLAM |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA074224 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00054-4858-25 (00054485825)
| NDC Package Code | 0054-4858-25 |
|---|---|
| Billing NDC | 00054485825 |
| Package | 100 TABLET in 1 BOTTLE (0054-4858-25) |
| Marketing Start Date | 2018-10-29 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.44818 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | TRIAZOLAM 0.125 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis